ArticleArchives of microbiology2025
Chimeric hBPI
Tianxiao Ma, Yang Wang, Chaoben Huang, Xulong Zhang, Yunqing An, Qi Zhang, Qingli Kong, Bin Cao
Abstract read
In one paragraphArticle in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Tianxiao MaDepartment of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, China.
Yang WangDepartment of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, China.
Chaoben HuangBeijing Anjun Genetech Co., LTD., Beijing, China.
Xulong ZhangDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Yunqing AnDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Qi ZhangDepartment of Respiratory Medicine, The First Hospital Affiliated to Army Medical University (Third Military Medical University), Chongqing, China.
Qingli KongDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. kongql@ccmu.edu.cn.
Bin CaoDepartment of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, China. caobin_ben@163.com.
Funding
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences CIFMS 2021-I2M-1-048Medical Innovation Capacity Enhancement Special Program of Capital Medical University CXZX 202308
6 · The paper itselfAbstract
The antimicrobial peptides, such as host immune system-derived human bactericidal/permeability-increasing protein (hBPI), are the potential drugs for antibiotic-resistant Gram-negative bacterial infection. However, whether the purified chimeric hBPI
Indexed as
Anti-Bacterial AgentsAntimicrobial Cationic PeptidesBlood ProteinsGram-Negative BacteriaGram-Negative Bacterial InfectionsRecombinant Fusion ProteinsAcinetobacter baumanniiAcinetobacter InfectionsAnimalsBiofilmsDrug Resistance, BacterialEscherichia coliFemaleHumansMiceMice, Inbred BALB CAnti-Bacterial AgentsAntimicrobial Cationic Peptidesbactericidal permeability increasing proteinBlood ProteinsPore Forming Cytotoxic ProteinsRecombinant Fusion ProteinsAntimicrobial peptidesBactericidal/permeability-increasing protein (BPI)Drug-resistant gram-negative bacteriaOpsonization
What OpenQuestion holds
Textmetadata
Read underepoch 390